Piergiuseppe A.
- Country
- Italy
- Department
- Heart Failure and Clinical Cardiology and Rehabilitation Department
Research Overview
- A Phase 3, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Levosimendan in Patients with Pulmonary Hypertension and HFpEF
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 441 of 981 partner sites.
Specializations
Heart Failure Management
This investigator specializes in treating various forms of heart failure, with particular emphasis on both reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF) conditions. Their research encompasses innovative therapeutic approaches for managing chronic cardiac conditions.
- Advanced Heart Failure Therapies
- Cardiac Function Enhancement
- Chronic Heart Failure Management
Their work extends to evaluating novel therapeutic agents for improving cardiac function and patient outcomes.
Cardiovascular Therapeutics
The investigator focuses on developing treatments for cardiovascular complications, including specialized approaches for patients with atrial fibrillation. Their expertise includes the evaluation of various therapeutic agents for stroke prevention and cardiac function improvement.
- Stroke Prevention Strategies
- Systemic Embolism Prevention
- Cardiac Biomarker Assessment
Their research involves comprehensive evaluation of cardiovascular treatment efficacy and safety profiles.
Integrated Cardiac Care
The investigator explores combination therapy approaches in cardiac treatment, with particular attention to diuretic therapy optimization and management of patients with concurrent kidney function impairment.
- Exercise Capacity Assessment
- Volume Management Strategies
- Comorbidity Management
Their work incorporates evaluation of multiple therapeutic combinations for optimal patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.